Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Maria Gasior

Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2014English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Related publications

Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

CNS Spectrums
PsychiatryMental HealthNeurology
2009English

Lisdexamfetamine Dimesylate for Preschool Children With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2020English

Efficacy of Lisdexamfetamine Dimesylate Throughout the Day in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Randomized, Controlled Trial

European Child and Adolescent Psychiatry
DevelopmentalMental HealthPediatricsEducational PsychologyPhilosophyPerinatologyPsychiatryMedicineChild Health
2013English

Lisdexamfetamine Dimesylate in the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy and Safety in Children and Adolescents

Revista de Psiquiatria Clinica
PsychiatryMental Health
2014English

Treatment Outcomes With Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder With Emotional Control Impairments

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2013English

Lisdexamfetamine in the Treatment of Adolescents and Children With Attention-Deficit/Hyperactivity Disorder

Adolescent Health, Medicine and Therapeutics
2012English

Atomoxetine Treatment in Children and Adolescents With Attention-Deficit Hyperactivity Disorder: What Are the Long-Term Health-Related Quality-Of-Life Outcomes?

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2006English

Health-Related Quality of Life in Children and Adolescents Who Have a Diagnosis of Attention-Deficit/Hyperactivity Disorder

Pediatrics
Child HealthPediatricsPerinatology
2004English

Sustained Treatment Effect in Attention-Deficit/Hyperactivity Disorder: Focus on Long-Term Placebo-Controlled Randomized Maintenance Withdrawal and Open-Label Studies

Therapeutics and Clinical Risk Management
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy